- Home
- ICMB vs LSB Comparison
ICMB vs LSB Comparison
Compare ICMB & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICMB
- LSB
- Stock Information
- Founded
- ICMB 2012
- LSB 2002
- Country
- ICMB United States
- LSB China
- Employees
- ICMB N/A
- LSB N/A
- Industry
- ICMB Finance: Consumer Services
- LSB
- Sector
- ICMB Finance
- LSB
- Exchange
- ICMB Nasdaq
- LSB NYSE
- Market Cap
- ICMB 44.8M
- LSB 53.6M
- IPO Year
- ICMB N/A
- LSB N/A
- Fundamental
- Price
- ICMB $3.18
- LSB $2.23
- Analyst Decision
- ICMB
- LSB
- Analyst Count
- ICMB 0
- LSB 0
- Target Price
- ICMB N/A
- LSB N/A
- AVG Volume (30 Days)
- ICMB 27.8K
- LSB 7.3K
- Earning Date
- ICMB 03-04-2025
- LSB 12-19-2024
- Dividend Yield
- ICMB 15.14%
- LSB N/A
- EPS Growth
- ICMB N/A
- LSB N/A
- EPS
- ICMB 0.29
- LSB N/A
- Revenue
- ICMB $24,827,371.00
- LSB $79,415,311.00
- Revenue This Year
- ICMB N/A
- LSB $39.33
- Revenue Next Year
- ICMB N/A
- LSB $75.61
- P/E Ratio
- ICMB $10.87
- LSB N/A
- Revenue Growth
- ICMB N/A
- LSB N/A
- 52 Week Low
- ICMB $2.91
- LSB $1.88
- 52 Week High
- ICMB $3.67
- LSB $11.20
- Technical
- Relative Strength Index (RSI)
- ICMB 66.63
- LSB 40.56
- Support Level
- ICMB $3.10
- LSB $2.10
- Resistance Level
- ICMB $3.23
- LSB $2.49
- Average True Range (ATR)
- ICMB 0.06
- LSB 0.22
- MACD
- ICMB 0.01
- LSB 0.00
- Stochastic Oscillator
- ICMB 76.19
- LSB 16.35
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.